Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications
- PMID: 3899457
- DOI: 10.2165/00003088-198510050-00005
Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications
Abstract
The literature on theophylline is confusing since in the same dose range one article will report linear kinetics while another will report non-linear kinetics. Single dose clearances and lower steady-state clearances of theophylline, recently reported in the literature, were used to estimate pooled Vmax and Km values of the Michaelis-Menten equation for 10 normal subjects. The mean Vmax was 1960 mg/day and the mean Km was 24.1 mg/L. These values were then utilised to: explain another set of different oral clearances following doses of 2 and 6 mg/kg reported in the literature; estimate relative effects of dose rate and type of input on absolute bioavailability; estimate AUC (0-infinity) as a function of single dose over the range 0 to 1500 mg; estimate the average steady-state serum concentration of theophylline (Cssav and steady-state oral clearance (CLsspo) as a function of dose rate in mg/day; illustrate how Michaelis-Menten kinetics alters the apparent first-order elimination rate constant and the half-life estimated from terminal log-linear plots at concentrations appreciably lower than the Km value; and illustrate how Michaelis-Menten kinetics affects the estimation of a zero-order absorption rate constant using the Wagner-Nelson method.
Similar articles
-
Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.Biopharm Drug Dispos. 1985 Apr-Jun;6(2):177-200. doi: 10.1002/bdd.2510060209. Biopharm Drug Dispos. 1985. PMID: 4005396
-
Incidence of apparent Michaelis-Menten kinetic behavior of theophylline and its parameters (Vmax and Km) among asthmatic children and adults.Ther Drug Monit. 1987;9(1):11-20. doi: 10.1097/00007691-198703000-00003. Ther Drug Monit. 1987. PMID: 3576655
-
Nonlinear theophylline elimination.Clin Pharmacol Ther. 1982 Mar;31(3):358-69. doi: 10.1038/clpt.1982.46. Clin Pharmacol Ther. 1982. PMID: 7060318
-
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001. Clin Pharmacokinet. 1984. PMID: 6370542 Review.
-
Aspects of theophylline clearance in children.Anaesth Intensive Care. 1997 Oct;25(5):497-501. doi: 10.1177/0310057X9702500508. Anaesth Intensive Care. 1997. PMID: 9352762 Review.
Cited by
-
Effects of alpha-interferon on theophylline pharmacokinetics and metabolism.Br J Clin Pharmacol. 1989 Jun;27(6):795-802. doi: 10.1111/j.1365-2125.1989.tb03442.x. Br J Clin Pharmacol. 1989. PMID: 2757895 Free PMC article. Clinical Trial.
-
Non-linear elimination and protein binding of probenecid.Eur J Clin Pharmacol. 1987;32(4):395-401. doi: 10.1007/BF00543976. Eur J Clin Pharmacol. 1987. PMID: 3609117
-
Adverse reactions and interactions with theophylline.Drug Saf. 1990 Jul-Aug;5(4):275-85. doi: 10.2165/00002018-199005040-00004. Drug Saf. 1990. PMID: 2198052 Review.
-
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003. Clin Pharmacokinet. 1995. PMID: 7648758 Review.
-
Food interactions with sustained-release theophylline preparations. A review.Clin Pharmacokinet. 1989 Mar;16(3):162-79. doi: 10.2165/00003088-198916030-00003. Clin Pharmacokinet. 1989. PMID: 2656048 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources